Glenmark Pharma - Trend sustained
Topic Statement: Glenmark Pharma, despite a minor correction, remains on a bullish trajectory with strong support levels.
Key Points:
1. A head and shoulders pattern led to a price breakdown and a brief correction.
2. The stock found support at the uptrend line, maintaining its bullish structure.
3. The price is at the 38.2% retracement level, a key support area previously held in July and August 2024.
Key Points:
1. A head and shoulders pattern led to a price breakdown and a brief correction.
2. The stock found support at the uptrend line, maintaining its bullish structure.
3. The price is at the 38.2% retracement level, a key support area previously held in July and August 2024.
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.